Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles White

Diagnostic Radiology Baltimore, MD Medical Doctor

NPI 1164414421 CMS profile 709961

22 S Greene St, Dept Of Radiology, Baltimore, MD 21201

Open in the dashboard

General payments

$93,245

51 records reported · program years 2019–2025

Research payments

$17,828

Paid to them · 5 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Charles White of Baltimore, MD is reported in the CMS Open Payments database as having received $93,245 across 51 general payments and $17,828 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,385 6
2025 Research $1,348 1
2024 Research $12,600 2
2023 General $6,679 3
2023 Research $3,881 2
2022 General $18,702 10
2021 General $2,275 1
2020 General $25,497 11
2019 General $36,706 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles White
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Charles White were reported at $3,385. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Charles White Diagnostic Radiology median Middle half National median
2019 $36,706 $108 $29–$318 $163
2020 $25,497 $65 $21–$252 $114
2021 $2,275 $92 $24–$292 $132
2022 $18,702 $104 $29–$294 $149
2023 $6,679 $110 $29–$337 $160
2024 $0 $113 $30–$356 $164
2025 $3,385 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $70,091 33 payments
  2. Philips Electronics North America Corporation $19,406 9 payments
  3. Guerbet LLC $3,385 6 payments
  4. Davol Inc. $131 1 payment
  5. Boston Scientific Corporation $120 1 payment
  6. Ge Healthcare $112 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $57,845 13 payments
  2. Consulting Fee $14,487 5 payments
  3. Travel and Lodging $5,474 9 payments
  4. Honoraria $5,325 2 payments
  5. Grant $3,991 1 payment
  6. Education $2,929 1 payment
  7. Food and Beverage $1,694 19 payments
  8. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $1,500 1 payment
Products named General payments · program years 2019–2025
  1. (0174) CT Premium High Serv $6,586 3 payments
  2. Elucirem $3,385 6 payments
  3. (9532) PD Other $3,185 1 payment
  4. (3920) CT Other $2,929 1 payment
  5. (4532) MR DXR OEM Und $2,365 1 payment
  6. (8334) IGT_D Peripheral $2,275 1 payment
  7. (1496) CT Equip Undiv $1,500 1 payment
  8. (174) CT Premium High Service $565 1 payment
  9. GENERAL - VASCULAR INTERVENTION $120 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. E.R. Squibb & Sons, L.L.C. $17,828 5 payments

Billing to Medicare

Part B · data year 2024 · 24 billing codes

Paid by Medicare

$169,159

Of which drugs: $868

Medicare patients

5,123

Average age 73

Services billed

24,988

2,665 women, 2,458 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 49%
Diabetes 47%
Ischemic heart disease 46%
Chronic kidney disease 43%
Heart failure 38%
COPD 35%
Atrial fibrillation 33%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 161 15,813 $827

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

56 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record